MIB-1 proliferative activity in invasive breast cancer measured by image analysis

Journal of Clinical Pathology

Volumn 49, Issue 11, 1996, Pages 926-930

  Querzoli, P ^a   Albonico, G ^a   Ferretti, S ^a   Rinaldi, R ^a   Magri, E ^a   Indelli, M ^b   Nenci, I ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Breast cancer; Image analysis; MIB 1; Overall survival; Proliferative activity

Indexed keywords

CELL NUCLEUS ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL;

EID: 0029806391     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.11.926     Document Type: Article

References (36)

1. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990;17:489-503.
2. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1990;1:199-206.
3. Cattoretti G, Becker MHG, Key G, Duchrou M, Schlter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
4. Key G, Becker MHG, Baron B, Duchrow M, Schluter C, Flad HD, et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed part of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993;6:629-36.
5. Key G, Becker MHG, Duchrow M, Scluter C, Gerdes J. New KI-67 equivalent murine monoclonal antibodies (MIB 1-3) prepared against recombinant parts of the KI-67 antigen. Anal Cell Pathol 1992;4:181-3.
6. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB 1. Histopathology 1993;22:355-60.
7. Hall PA, Levison DA. Assessment of cell proliferation in histological material. J Clin Pathol 1990;43:184-92.
8. Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-94.
9. Morris ES, Elston CW, Bell JA, Galea M, Blarney RW, Ellis IO. An evaluation of the cell cycle-associated monoclonal antibody Ki-S1 as a prognostic factor in primary invasive adenocarcinoma of the breast. J Pathol 1995;176:55-62.
10. Sampson SA, Kreipe H, Gillett CE, Smith P, Chaudary MA, Khan A, et al. KiS1 - a novel monoclonal antibody which recognizes proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma. J Pathol 1992;168:179-85.
11. Hermanek P, Sobin LH. UICC TNM Classification of malignant tumors. 4th edn, 2nd revision. Berlin: Springer-Verlag, 1992.
12. Querzoli P, Ferretti S, Albonico G, Magri E, Scapoli D, Indelli M, et al. Application of quantitative analysis to biologic profile evaluation in breast cancer. Cancer 1995;76: 2510-17.
13. Baddoura FK, Cohen C, Unger ER, DeRose PB, Chenggis M. Image analysis for quantitation of estrogen receptor in formalin-fixed paraffin-embedded sections of breast carcinoma. Mod Pathol 1991;4:91-5.
14. Linden MD, Torres FX, Kubus J, Zarbo RJ. Clinical application of morphologic and immunocytochemical assessments of cell proliferation. Am J Clin Pathol 1992; 97(Suppl):4-12.
15. Esteban JM, Chul A, Battifora H, Felder B. Predictive value of estrogen receptors evaluated by quantitative immunohistochemical analysis in breast cancer. Am J Clin Pathol 1994;102:9-12.
16. Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, et al. P53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 1993;85:965-70.
17. Lee E, Desu M. A computer program for comparing k samples with right censored data. Comp Progr Biomed 1972;2:315-21.
18. Marchetti E, Querzoli P, Marzola A, Bagni A, Ferretti S, Fabris G, et al Assessment of proliferative rate of breast cancer by Ki-67 monoclonal antibody. Mod Pathol 1990;3: 31-5.
19. Querzoli P, Marchetti E, Ferretti S, Albonico G, Orvieto E, Tassinari D, et al. Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer. Int J Biol Markers 1993;8:38.
20. Hall PA, Woods AL. Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet 1990;23:505-22.
21. Quinn CM, Wright NA. The clinical assessment of proliferation and growth in human tumours: evaluation as prognostic variables. J Pathol 1990;160:93-102.
22. 3H]-thymidyne labelling index in breast cancer. Cell Prolif 1991;24:437-45.
23. Fonatsch C, Duchrow M, Rieder H, Schulter C, Gerdes J. Assignment of the human Ki-67 gene (MK167) to 10q25-qter. Genomics 1991;11:476-77.
24. Gerdes J, Schlueter L, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-73.
25. Sahin AA, Ro J, Ro JY, Blick MB, El-Naggar AK, Ordonez NG, et al. Ki-67 immunostaining in node-negative stage I-II breast carcinoma. Cancer 1991;68:549-57.
26. Veronese SM, Gambacorta M. Detection of KI-67 proliferation rate in breast cancer. Correlation with clinical and pathological features. Am J Clin Pathol 1991;95:30-4.
27. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M, Lampertico P. Proliferation index as a prognostic marker in breast cancer. Cancer 1993;71:3926-31.
28. Barbareschi M, Girlando S, Mauri FM, Forti S, Eccher C, Mauri FA, et al. Qantitative growth fraction evaluation with MIB1 and Ki-67 antibodies in breast carcinomas. Am J Clin Pathol 1994;102:171-5.
29. Kerns BJM, Jordan PA, Faerman LL, Berchuck A, Bast RC, Layfield LJ. Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis. Am J Clin Pathol 1994;101:192-7.
30. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 1994;74:1921-6.
31. Finder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, et al. Assessment of the new proliferation marker MIB-1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 1995;71:146-9.
32. Keshgegian AA, Cnaan A. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-I. Am J Clin Pathol 1995;104:42-9.
33. Leong ASY, Vinyuvat S, Suthipintawong C, Milios J. A comparative study of cell proliferation markers in breast carcinomas. J Clin Pathol: Mol Pathol 1995;48:M83-7.
34. Jensen V, Ladekarl M, Holm-Nielsen P, Melsen F, Soerensen FB. The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node negative breast cancer. J Pathol 1995;176:343-52.
35. Bacus JW, Grace LJ. An optical microscope system of standardized cell measurements and analysis. Applied Optics 1987;16:3280-93.
36. Bacus SS, Goldschmidt R, Chin D, Moran G, Weimberg D, Bacus JW. Biological grading of breast cancer using antibodies to proliferating cells and other markers. Am J Pathol 1989;135:783-92.